Literature DB >> 8603620

Predictors of intractable epilepsy in childhood: a case-control study.

A T Berg1, S R Levy, E J Novotny, S Shinnar.   

Abstract

Little is known about what factors predict intractable epilepsy at the time of initial diagnosis. We performed a case-control study to identify early predictors of medically intractable epilepsy in children. Cases were children who had an average of one seizure or more a month over a 2-year period and who, during that time, had failed trials of at least three different antiepileptic drugs (AEDs). Controls were children who had epilepsy, who had been seizure-free for > or = 2 years, and who had never, before becoming seizure-free, met the definition for intractable epilepsy. Strong univariate associations were noted between intractability and several factors: infantile spasms (IS) remote symptomatic epilepsy, a history of status epilepticus (SE) before the diagnosis of epilepsy, neonatal seizures, and microcephaly. Cases were significantly younger than controls at onset (1.8 vs. 5.8 years); this was not due solely to cases with onset during the first year of life but was an association apparent throughout the age range studied. With multiple logistic regression, independent predictors of intractability were IS, odds ratio (OR) = 10.42, p = 0.03; age at onset with a decreasing risk with increasing age, OR = 0.77 per year, p less than 0.0001; remote symptomatic epilepsy, OR = 2.24, p = 0.04; and SE, OR = 3.30, p = 0.04. These findings complement those of recent cohort studies of remission of epilepsy and provide useful leads for future prospective studies of intractable epilepsy.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8603620     DOI: 10.1111/j.1528-1157.1996.tb00507.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  20 in total

1.  Development of later life spontaneous seizures in a rodent model of hypoxia-induced neonatal seizures.

Authors:  Sanjay N Rakhade; Peter M Klein; Thanthao Huynh; Cristina Hilario-Gomez; Bela Kosaras; Alexander Rotenberg; Frances E Jensen
Journal:  Epilepsia       Date:  2011-03-02       Impact factor: 5.864

2.  Remission and relapse in a drug-resistant epilepsy population followed prospectively.

Authors:  Brian Callaghan; Malka Schlesinger; William Rodemer; John Pollard; Dale Hesdorffer; W Allen Hauser; Jacqueline French
Journal:  Epilepsia       Date:  2011-01-26       Impact factor: 5.864

3.  Effect of age on cognitive sequelae following early life seizures in rats.

Authors:  Havisha B Karnam; Qian Zhao; Tatiana Shatskikh; Gregory L Holmes
Journal:  Epilepsy Res       Date:  2009-04-22       Impact factor: 3.045

4.  Practice parameter: Evaluation of the child with microcephaly (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society.

Authors:  Stephen Ashwal; David Michelson; Lauren Plawner; William B Dobyns
Journal:  Neurology       Date:  2009-09-15       Impact factor: 9.910

Review 5.  Identification of pharmacoresistant epilepsy.

Authors:  Anne T Berg
Journal:  Neurol Clin       Date:  2009-11       Impact factor: 3.806

Review 6.  Refractory epilepsy in children.

Authors:  Satinder Aneja; Puneet Jain
Journal:  Indian J Pediatr       Date:  2014-08-09       Impact factor: 1.967

7.  Remission of epilepsy after two drug failures in children: a prospective study.

Authors:  Anne T Berg; Susan R Levy; Francine M Testa; Ramona D'Souza
Journal:  Ann Neurol       Date:  2009-05       Impact factor: 10.422

8.  Long-term follow-up of a large cohort with focal epilepsy of unknown cause: deciphering their clinical and prognostic characteristics.

Authors:  Arife Çimen Atalar; Ebru Nur Vanlı-Yavuz; Ebru Yılmaz; Nerses Bebek; Betül Baykan
Journal:  J Neurol       Date:  2019-12-02       Impact factor: 4.849

9.  Can we predict the response in the treatment of epilepsy with vagus nerve stimulation?

Authors:  A Arcos; L Romero; M Gelabert; A Prieto; J Pardo; X Rodriguez Osorio; M A Arráez
Journal:  Neurosurg Rev       Date:  2014-05-18       Impact factor: 3.042

Review 10.  Antiepileptic drug development in children: considerations for a revisited strategy.

Authors:  Catherine Chiron; Olivier Dulac; Gerard Pons
Journal:  Drugs       Date:  2008       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.